One targets a single hormone pathway
Prescription GLP-1 receptor agonists are designed to deliver a strong, sustained signal by directly activating GLP-1 receptors and resisting rapid breakdown in the body
Orforglipron (LY3502970), a novel, oral nonpeptide glucagonlike peptide1 receptor agonist: a Phase 1a, blinded, placebocontrolled, randomized, singleand multipleascendingdose study in healthy participants
We know that these drugs not only lead to weight loss, but also provide some protection against diabetes, heart, kidney and liver disease
Slower gastric emptying helps blunt post-meal glucose spikes and can prolong feelings of fullness after eating
Increase insulin, which naturally lowers your blood sugar